Rigevidon 30mcg/150mcg Tablet POM, R x63

White, circular, biconvex, coated tablets - each coated tablet contains 150 micrograms levonorgestrel and 30 micrograms ethinylestradiol.

Therapeutic indications:
• Oral contraception and the recognised gynaecological indications for such oestrogen progesterone combinations.
• The decision to prescribe Rigevidon should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Rigevidon compares with other combined hormonal contraceptives (CHCs)

Features

Nature and contents of container:
• Tablets are packed in PVC/PVDC/Aluminium blisters
• Presentation: Pack sizes - 21 coated tablets (1 blister of 21), 63 coated tablets (3 blisters of 21), 126 coated tablets (6 blisters of 21), 273 coated tablets (13 blisters of 21).

Special precautions for storage:
• Store below 25° C